Case Identification
Case name: Heckler v. Chaney
Court: United States Supreme Court
Jurisdiction: Federal
Year: 1985
Citation: 470 U.S. 821
Claim Presented
Respondents, death row inmates, petitioned the Food and Drug Administration to take enforcement action regarding the use of certain drugs in lethal injections administered by state authorities. Respondents argued that the drugs were being used for purposes not approved by the FDA and in a manner that violated the Federal Food, Drug, and Cosmetic Act. The FDA declined to take the requested enforcement action, determining that such action was not an appropriate use of its limited enforcement resources. Respondents subsequently sought judicial review of the FDA’s decision not to institute enforcement proceedings, contending that the agency’s refusal to act was arbitrary, capricious, and an abuse of discretion under the Administrative Procedure Act.
Authority Cited
Administrative Procedure Act, 5 U.S.C. § 701 et seq., particularly § 701(a)(2), which provides that judicial review is not available to the extent that agency action is committed to agency discretion by law.
Court’s Analysis
The Court held that an agency’s decision not to institute enforcement proceedings is presumptively immune from judicial review under 5 U.S.C. § 701(a)(2). The Court reasoned that decisions whether to initiate enforcement actions involve complicated balancing of numerous factors that are within the particular expertise of the agency, including assessment of whether a violation has occurred, determination of agency enforcement priorities, allocation of limited enforcement resources, and evaluation of the likelihood that enforcement action would prove successful. The Court noted that such decisions are generally committed to absolute agency discretion. The Court stated that this presumption of unreviewability may be rebutted in cases where the relevant statute provides meaningful standards for defining the limits of the agency’s enforcement discretion or otherwise supplies judicially manageable standards for review. The Court examined the statutory provisions governing the FDA and found no such meaningful standards that would circumscribe the agency’s enforcement discretion in this matter.
Disposition
The judgment of the Court of Appeals, which had held that the FDA’s decision was subject to judicial review, was reversed. The Supreme Court’s judgment affirmed the agency’s decision not to take enforcement action and held that such decision was not subject to judicial review.
Procedural Outcome
Respondents’ claim for judicial review was dismissed. The agency’s exercise of enforcement discretion was upheld as committed to agency discretion by law and therefore unreviewable under the Administrative Procedure Act.
Archival Note
This entry documents the judicial record in Heckler v. Chaney as preserved in the official reports at 470 U.S. 821. The decision addressed the scope of agency enforcement discretion under the Administrative Procedure Act and clarified the limits on judicial review of agency decisions not to initiate enforcement actions. The holding established a presumption that such decisions are committed to agency discretion by law and are therefore not subject to judicial review absent statutory standards providing meaningful limits on that discretion.